Teon Therapeutics

About:

Teon Therapeutics is a a biopharmaceutical company developing small molecules that inhibit the immunosuppressive cancer signaling pathways.

Website: https://www.teontherapeutics.com

Top Investors: Northern Light Venture Capital, Oriental Fortune Capital, Oriza Ventures, Kaitai Capital, Oceanpine Capital

Description:

Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.